FAMILY PLANNING: Edited by Paul D. BlumenthalInjectable contraception: updates and innovationSchivone, Gilliana; Dorflinger, Lanetab; Halpern, VerabAuthor Information aStanford University School of Medicine, Stanford, California bFHI 360, Durham, North Carolina, USA Correspondence to Gillian Schivone, MD, Stanford University School of Medicine, 300 Pasteur Drive GG332, Stanford, CA 94305, USA. Tel: +1 650 723 8549; e-mail: [email protected] Current Opinion in Obstetrics and Gynecology: December 2016 - Volume 28 - Issue 6 - p 504-509 doi: 10.1097/GCO.0000000000000329 Buy Metrics Abstract Purpose of review Injectable contraception is a highly effective form of birth control that is globally popular. Recent research has focused on ways to make injectables such as depot medroxyprogesterone acetate (DMPA) more accessible and to improve the side-effect profile of injectables. This review will focus on new directions and approaches to the use of injectable contraception. Recent findings Research in the area of injectable contraception has focused on improving access for women through home or self-injection, and also task-shifting and community-based distribution in low-resource areas. Specific to DMPA, studies have focused on lowering the overall dose of medication while maintaining efficacy, and improving drug-delivery systems. More research into the association between DMPA and HIV is needed, and also the effects of administration of DMPA at the time of medication abortion. Summary Injectable contraceptives are an important part of the global method mix of highly effective birth control. Improving the accessibility and side effect profile of commodities such as DMPA will make injectables even more valuable for women seeking effective contraception. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.